Original Articles

Contributors: All authors designed the study, acquired and analysed the data, drafted the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

Conflicts of Interest: All authors have disclosed no conflicts of interest.

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethics Approval: This research was approved by the Kowloon West Cluster Research Ethics Committee (Ref KW/EX-18-071(123-10)).

Full Article in PDF

Abstract

Objective

Hip pain is the main indication for hip radiographs, which comprise a significant proportion of outpatient

Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel for Patients with Inoperable Pancreatic Cancer: Experience at a Single Oncology Centre

TY Lee, MHC Lam, KM Cheung, HC Cheng, RKC Ngan, KH Wong

ORIGINAL ARTICLE

Hong Kong J Radiol 2020 Mar;23(1):27-33

https://doi.org/10.12809/hkjr2017076

Gemcitabine Plus Nanoparticle Albumin-bound Paclitaxel for Patients with Inoperable Pancreatic Cancer: Experience at a Single Oncology Centre

TY Lee, MHC Lam, KM Cheung, HC Cheng, RKC Ngan, KH Wong

Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong

Correspondence: Dr TY Lee, Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong. Email: lukelee2@gmail.com

Submitted: 3 Feb 2019; Accepted: 23 Apr 2019.

Contributors: TYL, HCC, RKCN and KHW designed the study. TYL, MHCL and KMC acquired the data. TYL drafted the manuscript. All authors contributed to data analysis, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

Conflicts of Interest: As editors of the journal, TY Lee, MHC Lam, and RKC Ngan were not involved in the peer review process. Other authors have no conflicts of interest to disclose.

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethics Approval: The study was approved by the Kowloon Central / Kowloon East institution’s Research Ethics Committee (Ref KC/KE-18- 0177/ER-1) and was conducted in compliance with the Declaration of Helsinki.

Full Article in PDF

Abstract

Objective

To review the outcomes of gemcitabine plus nanoparticle albumin-bound (nab)-paclitaxel for patients with

Risk of Radiation Pneumonitis after Post-lobectomy Thoracic Radiotherapy for Non-small-cell Lung Cancer

W Chan, JSF Nyaw, WWY Tin, EKC Lee, SH Lo, ACH Liu, FCS Wong

ORIGINAL ARTICLE

Hong Kong J Radiol 2020 Mar;23(1):20-6

https://doi.org/10.12809/hkjr2017084

Risk of Radiation Pneumonitis after Post-lobectomy Thoracic Radiotherapy for Non-small-cell Lung Cancer

W Chan, JSF Nyaw, WWY Tin, EKC Lee, SH Lo, ACH Liu, FCS Wong

Department of Clinical Oncology, Tuen Mun Hospital, Tuen Mun, Hong Kong

Correspondence: Dr W Chan, Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong. Email: cw698@ha.org.hk

Submitted: 14 Feb 2019; Accepted: 29 Jul 2019.

Contributors: All authors contributed to the concept of study, acquisition and analysis of data, drafting of the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

Conflicts of Interest: As an editor of the journal, FCS Wong was not involved in the peer review process. Other authors have disclosed no conflicts of interest.

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethics Approval: This retrospective study was approved by the New Territories West Research Ethics Committee (Ref NTWC/CREC/18053).

Full Article in PDF

Abstract

Introduction

Patients who had lobectomy prior to thoracic radiotherapy may be more prone to developing radiation

Treatment Outcomes in Patients Receiving Regorafenib for Metastatic Colon Cancer

CME

L Fok, KM Cheung, YL Kwok, KH Wong

ORIGINAL ARTICLE CME

Hong Kong J Radiol 2020 Mar;23(1):12-9

https://doi.org/10.12809/hkjr2017130

Treatment Outcomes in Patients Receiving Regorafenib for Metastatic Colon Cancer

L Fok, KM Cheung, YL Kwok, KH Wong

Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong

Correspondence: Dr L Fok, Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong. Email: leslie.fok@link.cuhk.edu.hk

Submitted: 7 Jun 2019; Accepted: 3 Sep 2019.

Contributors: LF and KMC designed the study and acquired the data. All authors contributed to the analysis of data, drafted the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

Conflicts of Interest: The authors have no conflicts of interest to disclose.

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethics Approval: This study was approved by the Research Ethics Committee (Kowloon Central/Kowloon East) of the Hospital Authority, Hong Kong (Ref KC/KE-19-0046-ER/4). The requirement for patient consent was waived. All patients were treated in compliance with the Declaration of Helsinki.

Full Article in PDF

Abstract

Introduction

To review the treatment outcomes of patients with chemorefractory metastatic colorectal cancer receiving

Breast Cancer Patients Treated by Helical Tomotherapy, Intensity-modulated Radiotherapy, and Volumetric Arc Therapy: Comparison of Lung Doses

CME

WK Ho, RKC Ngan, CWY Yip, FKH Lee, JCF Lui

ORIGINAL ARTICLE CME

Hong Kong J Radiol 2020 Mar;23(1):4-11

https://doi.org/10.12809/hkjr2016959

Breast Cancer Patients Treated by Helical Tomotherapy, Intensity-modulated Radiotherapy, and Volumetric Arc Therapy: Comparison of Lung Doses

WK Ho, RKC Ngan, CWY Yip, FKH Lee, JCF Lui

Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong

Correspondence: Dr WK Ho, Department of Clinical Oncology, Queen Elizabeth Hospital, Jordan, Hong Kong. Email: hwk757@ha.org.hk

Submitted: 12 Feb 2018; Accepted: 2 Oct 2018.

Contributors: WKH and RKCN designed the study. WKH, CWYY, FKHL and JCFL acquired the data. WKH and RKCN analysed the data, drafted the manuscript, and had critical revision of the manuscript for important intellectual content. All authors had full access to the data, contributed to the study, approved the final version for publication, and take responsibility for its accuracy and integrity.

Conflicts of Interest: As an editor of the journal, RKC Ngan was not involved in the peer review process. Other authors have disclosed no conflicts of interest.

Funding/Support: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Ethics Approval: This study has been approved by the Research Ethics Committee of the Hospital Authority (Ref KC/KE-18-0002/ER-2). The requirement for patient consent was waived by the Research Ethics Committee.